Impact of the COVID-19 pandemic on blood pressure control: a nationwide home blood pressure monitoring study.
Blood pressure control
COVID-19
Home blood pressure
Hypertension
Office blood pressure
Journal
Hypertension research : official journal of the Japanese Society of Hypertension
ISSN: 1348-4214
Titre abrégé: Hypertens Res
Pays: England
ID NLM: 9307690
Informations de publication
Date de publication:
02 2022
02 2022
Historique:
received:
11
07
2021
accepted:
30
09
2021
revised:
15
08
2021
pubmed:
4
12
2021
medline:
22
1
2022
entrez:
3
12
2021
Statut:
ppublish
Résumé
There are concerns that hypertension control may decrease during the COVID-19 pandemic. This study evaluated the impact of the COVID-19 pandemic on office blood pressure (OBP) and home blood pressure monitoring (HBPM) control in a large Brazilian nationwide sample. The results of an adjusted spline analysis evaluating the trajectory of OBP and HBPM control from 01/Jan/2019 to 31/Dec/2020 among independent participants who were untreated (n = 24,227) or treated (n = 27,699) with antihypertensive medications showed a modest and transient improvement in OBP control among treated individuals, which was restricted to the early months following the COVID-19 pandemic outbreak. Furthermore, slight reductions in OBP and HBPM values were detected in the early months following the COVID-19 pandemic outbreak among treated (n = 987) participants for whom blood pressure measurements before and during the pandemic were available, but not among untreated (n = 495) participants. In conclusion, we found no major adverse influence of the COVID-19 pandemic on OBP and HBPM control in a large nationwide sample.
Identifiants
pubmed: 34857897
doi: 10.1038/s41440-021-00784-1
pii: 10.1038/s41440-021-00784-1
pmc: PMC8636576
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
364-368Informations de copyright
© 2021. The Author(s), under exclusive licence to The Japanese Society of Hypertension.
Références
European Society of Hypertension Corona-virus Disease 19 Task Force. The corona-virus disease 2019 pandemic compromised routine care for hypertension: a survey conducted among excellence centers of the European Society of Hypertension. J Hypertens. 2021;39:190–5.
doi: 10.1097/HJH.0000000000002703
Ran J, Song Y, Zhuang Z, Han L, Zhao S, Cao P, et al. Blood pressure control and adverse outcomes of COVID-19 infection in patients with concomitant hypertension in Wuhan, China. Hypertens Res. 2020;43:1267–76.
doi: 10.1038/s41440-020-00541-w
Geng L, He C, Kan H, Zhang K, Mao A, Zhang C, et al. The association between blood pressure levels and mortality in critically ill patients with COVID-19 in Wuhan, China: a case-series report. Hypertens Res. 2021;44:368–70.
doi: 10.1038/s41440-020-00594-x
Zhang S, Zhou X, Chen Y, Wang L, Zhu B, Jiang Y, et al. Changes in Home Blood Pressure Monitored Among Elderly Patients With Hypertension During the COVID-19 Outbreak: A Longitudinal Study in China Leveraging a Smartphone-Based Application. Circ Cardiovasc Qual Outcomes. 2021;14:e007098.
doi: 10.1161/CIRCOUTCOMES.120.007098
Fosco MJ, Silva P, Taborda GA, Ahumada L. Association between mandatory lockdown due to COVID-19 and severe arterial hypertension. Medicina 2020;80:25–9.
pubmed: 33481729
Pengo MF, Albini F, Guglielmi G, Mollica C, Soranna D, Zambra G, et al. Home blood pressure during COVID-19-related lockdown in patients with hypertension. Eur J Prev Cardiol. 2021. https://doi.org/10.1093/eurjpc/zwab010 .
doi: 10.1093/eurjpc/zwab010
pubmed: 33899916
pmcid: 8227353
Girerd N, Meune C, Duarte K, Vercamer V, Lopez-Sublet M, Mourad JJ. Evidence of a Blood Pressure Reduction During the COVID-19 Pandemic and Associated Lockdown Period: Insights from e-Health Data. Telemed J E Health. 2021. https://doi.org/10.1089/tmj.2021.0006 .
doi: 10.1089/tmj.2021.0006
pubmed: 34101507
Coronavirus Brazil. https://www.worldometers.info/coronavirus/country/brazil/ .
Feitosa ADM, Mota-Gomes MA, Barroso WS, Miranda RD, Barbosa ECD, Pedrosa RP, et al. Blood pressure cutoffs for white-coat and masked effects in a large population undergoing home blood pressure monitoring. Hypertens Res. 2019;42:1816–23.
doi: 10.1038/s41440-019-0298-3
Feitosa ADM, Mota-Gomes MA, Barroso WS, Miranda RD, Barbosa ECD, Pedrosa RP, et al. Relationship between office isolated systolic or diastolic hypertension and white-coat hypertension across the age spectrum: a home blood pressure study. J Hypertens. 2020;38:663–70.
doi: 10.1097/HJH.0000000000002320
Feitosa ADM, Mota-Gomes MA, Barroso WS, Miranda RD, Barbosa ECD, Pedrosa RP, et al. Correlation between office and home blood pressure in clinical practice: a comparison with 2017 American College of Cardiology/American Heart Association Hypertension Guidelines recommendations. J Hypertens. 2020;38:179–81.
doi: 10.1097/HJH.0000000000002265
Feitosa ADM, Mota-Gomes MA, Barroso WS, Miranda RD, Barbosa ECD, Brandão AA, et al. The impact of changing home blood pressure monitoring cutoff from 135/85 to 130/80 mmHg on hypertension phenotypes. J Clin Hypertens. 2021;23:1447–51.
doi: 10.1111/jch.14261
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. ESC/ESH Guidelines for the management of arterial hypertension. J Hypertens. 2018;2018:1953–2041.
doi: 10.1097/HJH.0000000000001940
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382:1708–20.
doi: 10.1056/NEJMoa2002032